Cargando…

Inflammatory signature of cerebellar neurodegeneration during neonatal hyperbilirubinemia in Ugt1(-/-) mouse model

BACKGROUND: Severe hyperbilirubinemia is toxic during central nervous system development. Prolonged and uncontrolled high levels of unconjugated bilirubin lead to bilirubin-induced neurological damage and eventually death by kernicterus. Bilirubin neurotoxicity is characterized by a wide array of ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Vodret, Simone, Bortolussi, Giulia, Jašprová, Jana, Vitek, Libor, Muro, Andrés F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366125/
https://www.ncbi.nlm.nih.gov/pubmed/28340583
http://dx.doi.org/10.1186/s12974-017-0838-1
_version_ 1782517533514924032
author Vodret, Simone
Bortolussi, Giulia
Jašprová, Jana
Vitek, Libor
Muro, Andrés F.
author_facet Vodret, Simone
Bortolussi, Giulia
Jašprová, Jana
Vitek, Libor
Muro, Andrés F.
author_sort Vodret, Simone
collection PubMed
description BACKGROUND: Severe hyperbilirubinemia is toxic during central nervous system development. Prolonged and uncontrolled high levels of unconjugated bilirubin lead to bilirubin-induced neurological damage and eventually death by kernicterus. Bilirubin neurotoxicity is characterized by a wide array of neurological deficits, including irreversible abnormalities in motor, sensitive and cognitive functions, due to bilirubin accumulation in the brain. Despite the abundant literature documenting the in vitro and in vivo toxic effects of bilirubin, it is unclear which molecular and cellular events actually characterize bilirubin-induced neurodegeneration in vivo. METHODS: We used a mouse model of neonatal hyperbilirubinemia to temporally and spatially define the response of the developing cerebellum to the bilirubin insult. RESULTS: We showed that the exposure of developing cerebellum to sustained bilirubin levels induces the activation of oxidative stress, ER stress and inflammatory markers at the early stages of the disease onset. In particular, we identified TNFα and NFKβ as key mediators of bilirubin-induced inflammatory response. Moreover, we reported that M1 type microglia is increasingly activated during disease progression. Failure to counteract this overwhelming stress condition resulted in the induction of the apoptotic pathway and the generation of the glial scar. Finally, bilirubin induced the autophagy pathway in the stages preceding death of the animals. CONCLUSIONS: This study demonstrates that inflammation is a key contributor to bilirubin damage that cooperates with ER stress in the onset of neurotoxicity. Pharmacological modulation of the inflammatory pathway may be a potential intervention target to ameliorate neonatal lethality in Ugt1 (-/-) mice. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-017-0838-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5366125
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53661252017-03-28 Inflammatory signature of cerebellar neurodegeneration during neonatal hyperbilirubinemia in Ugt1(-/-) mouse model Vodret, Simone Bortolussi, Giulia Jašprová, Jana Vitek, Libor Muro, Andrés F. J Neuroinflammation Research BACKGROUND: Severe hyperbilirubinemia is toxic during central nervous system development. Prolonged and uncontrolled high levels of unconjugated bilirubin lead to bilirubin-induced neurological damage and eventually death by kernicterus. Bilirubin neurotoxicity is characterized by a wide array of neurological deficits, including irreversible abnormalities in motor, sensitive and cognitive functions, due to bilirubin accumulation in the brain. Despite the abundant literature documenting the in vitro and in vivo toxic effects of bilirubin, it is unclear which molecular and cellular events actually characterize bilirubin-induced neurodegeneration in vivo. METHODS: We used a mouse model of neonatal hyperbilirubinemia to temporally and spatially define the response of the developing cerebellum to the bilirubin insult. RESULTS: We showed that the exposure of developing cerebellum to sustained bilirubin levels induces the activation of oxidative stress, ER stress and inflammatory markers at the early stages of the disease onset. In particular, we identified TNFα and NFKβ as key mediators of bilirubin-induced inflammatory response. Moreover, we reported that M1 type microglia is increasingly activated during disease progression. Failure to counteract this overwhelming stress condition resulted in the induction of the apoptotic pathway and the generation of the glial scar. Finally, bilirubin induced the autophagy pathway in the stages preceding death of the animals. CONCLUSIONS: This study demonstrates that inflammation is a key contributor to bilirubin damage that cooperates with ER stress in the onset of neurotoxicity. Pharmacological modulation of the inflammatory pathway may be a potential intervention target to ameliorate neonatal lethality in Ugt1 (-/-) mice. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-017-0838-1) contains supplementary material, which is available to authorized users. BioMed Central 2017-03-24 /pmc/articles/PMC5366125/ /pubmed/28340583 http://dx.doi.org/10.1186/s12974-017-0838-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Vodret, Simone
Bortolussi, Giulia
Jašprová, Jana
Vitek, Libor
Muro, Andrés F.
Inflammatory signature of cerebellar neurodegeneration during neonatal hyperbilirubinemia in Ugt1(-/-) mouse model
title Inflammatory signature of cerebellar neurodegeneration during neonatal hyperbilirubinemia in Ugt1(-/-) mouse model
title_full Inflammatory signature of cerebellar neurodegeneration during neonatal hyperbilirubinemia in Ugt1(-/-) mouse model
title_fullStr Inflammatory signature of cerebellar neurodegeneration during neonatal hyperbilirubinemia in Ugt1(-/-) mouse model
title_full_unstemmed Inflammatory signature of cerebellar neurodegeneration during neonatal hyperbilirubinemia in Ugt1(-/-) mouse model
title_short Inflammatory signature of cerebellar neurodegeneration during neonatal hyperbilirubinemia in Ugt1(-/-) mouse model
title_sort inflammatory signature of cerebellar neurodegeneration during neonatal hyperbilirubinemia in ugt1(-/-) mouse model
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366125/
https://www.ncbi.nlm.nih.gov/pubmed/28340583
http://dx.doi.org/10.1186/s12974-017-0838-1
work_keys_str_mv AT vodretsimone inflammatorysignatureofcerebellarneurodegenerationduringneonatalhyperbilirubinemiainugt1mousemodel
AT bortolussigiulia inflammatorysignatureofcerebellarneurodegenerationduringneonatalhyperbilirubinemiainugt1mousemodel
AT jasprovajana inflammatorysignatureofcerebellarneurodegenerationduringneonatalhyperbilirubinemiainugt1mousemodel
AT viteklibor inflammatorysignatureofcerebellarneurodegenerationduringneonatalhyperbilirubinemiainugt1mousemodel
AT muroandresf inflammatorysignatureofcerebellarneurodegenerationduringneonatalhyperbilirubinemiainugt1mousemodel